Article

Long-term Cardiac Effects of Modern Treatment for Hodgkin’s Lymphoma

2024-01-02

Abstract excerpt

<h4>Background: </h4> Hodgkin’s lymphoma (HL) is a hematological malignancy that affects both children and young adults. Traditional treatment is associated with a life-time prevalence of cardiac disease exceeding 50%. In the late 1990s protocols were modified to reduce cancer therapy-related adverse cardiac effects. This study aimed to assess the long-term impact of advances in treatment protocols on the cardiac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4e9bcddd-ed08-5291-bf6e-7ea4bddab389
DOI: 10.21203/rs.3.rs-3759165/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Long-term Cardiac Effects of Modern Treatment for Hodgkin’s LymphomaDOI 10.21203/rs.3.rs-3759165/v1Read

Prevalence and Effects of Late Cardiotoxicity induced by Anthracyclines and/or Anti- HER2 Antibodies in Patients with Breast Cancer: a real world studySemantic proximity Read

Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from southern Italy cancer centersSemantic proximity Read

Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause.Semantic proximity Read

Outcomes of Pericardiectomy for Constrictive Pericarditis following Mediastinal IrradiationSemantic proximity Read

Risk of heart disease following breast cancer: results from a population-based cohort studySemantic proximity Read

Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patientsSemantic proximity Read

Effect of Active Cancer on the Cardiac Phenotype: A Cardiac Magnetic Resonance Imaging-Based Study of Myocardial Tissue Health and Deformation in Patients With Chemotherapy-Naïve Cancer.Semantic proximity Read

Post-chemotherapy Cardiotoxicity in Women With Breast CancerSemantic proximity Read

Predictive Value of Left Ventricular 18F-FDG PET/CT Derived Parameters and Uptake Patterns for Chemotherapy-Induced Cardiotoxicity in Patients with LymphomaSemantic proximity Read

Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort studySemantic proximity Read

Left Atrial Volume Index, Other Systolic and Diastolic Transthoracic Echocardiographic Parameters as Early Predictors for Asymptomatic Trastuzumab Target Cancer Therapy-Related Cardiac Dysfunction among HER2-Positive Breast Cancer Patients at a Tertiary Medical Center in Metro Manila – a Single-Center Prospective Cohort StudySemantic proximity Read

Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer without Risk Factors of Cardiotoxicity. Possibility of Omitting Cardiac Monitoring during Treatment.Semantic proximity Read